Today: 27 April 2026

Cisco Systems Stock Today: AI Deals, Analyst Upgrades and Big-Money Moves – November 30, 2025 Update

Cisco Systems Stock Today: AI Deals, Analyst Upgrades and Big-Money Moves – November 30, 2025 Update

Cisco Systems closed at $76.94 on November 28, near its 52-week high, after reporting Q1 FY 2026 revenue of $14.9 billion, up 8% year-on-year. Shares have climbed nearly 30% over the past year, outpacing the S&P 500. The company raised guidance for the next quarter and full year, and returned $3.6 billion to shareholders through dividends and buybacks.
30 November 2025
···
Nebius Group N.V. Stock (NBIS) Today: Meta Deal, Microsoft Contract and Hedge Fund Buying – 30 November 2025 Update

Nebius Group N.V. Stock (NBIS) Today: Meta Deal, Microsoft Contract and Hedge Fund Buying – 30 November 2025 Update

Nebius Group N.V. shares have surged over 240% year-to-date but remain about 30% below their 52-week high after recent volatility. New filings show another hedge fund has started a position in the company. Nebius recently closed at $94.87, with a market cap near $24–28 billion, and its $17.4 billion AI infrastructure deal with Microsoft remains a key driver.
30 November 2025
Adobe Stock (ADBE) on 30 November 2025: Price, Analyst ‘Hold’, AI Ambitions and Holiday E‑Commerce Tailwinds

Adobe Stock (ADBE) on 30 November 2025: Price, Analyst ‘Hold’, AI Ambitions and Holiday E‑Commerce Tailwinds

Adobe shares closed near $320 on November 30, down almost 39% over 12 months and close to their 52-week low. Wall Street’s consensus rating is “Hold,” with an average 12-month price target of $429, implying 34% upside. Recent earnings beat forecasts, with quarterly revenue up 10.7% year over year. BLI Banque de Luxembourg trimmed its position in Adobe, according to MarketBeat.
30 November 2025
··
Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical shares closed at $573.48 on November 28, 2025, giving the company a market cap near $203.6 billion. Institutional investors hold about 89% of the float, with recent filings showing modest increases from firms like Grantham Mayo and Schroder. The stock is up roughly 30% from October lows after strong earnings, but has underperformed the Nasdaq Composite in some November periods. Analyst consensus remains “Moderate Buy.”
30 November 2025
··
Chevron (CVX) Stock on November 30, 2025: Record Output, 10% Cash‑Flow Target and a High‑Yield Test for Investors

Chevron (CVX) Stock on November 30, 2025: Record Output, 10% Cash‑Flow Target and a High‑Yield Test for Investors

Chevron shares closed at $151.13 on November 28, valuing the company at about $300 billion, roughly 10% below its 52-week high. Q3 2025 results showed record oil production of 4.1 million BOE/d, $3.5 billion in earnings, and $9.4 billion in cash flow. The Hess acquisition boosted volumes but weighed on profits due to integration costs. Chevron’s dividend yield stands near 4.6%, with a 38-year streak of increases.
30 November 2025
··
AI Startup Valuations Are Tripling in Months as Mega-Rounds Flood Healthtech and Deep Tech

AI Startup Valuations Are Tripling in Months as Mega-Rounds Flood Healthtech and Deep Tech

US AI startups raised over $1.5 billion in the final week of November 2025, led by $600 million for Physical Intelligence and $298 million for Function Health. At least 49 US AI firms have secured $100 million-plus rounds this year, with valuations often doubling or tripling within months. Healthcare AI dominates new funding. OpenAI’s ecosystem is now linked to nearly $100 billion in partner debt.
30 November 2025
·
Pfizer (PFE) Stock on November 30, 2025: Institutional Buying, Metsera Deal and a 6.7% Dividend Yield

Pfizer (PFE) Stock on November 30, 2025: Institutional Buying, Metsera Deal and a 6.7% Dividend Yield

Pfizer shares closed at $25.74 on November 28, 2025, down 1.8% over the past year. Regulatory filings show new institutional buying, and the company completed a Metsera acquisition worth up to $10 billion. Pfizer reduced its BioNTech stake by 54.7% and raised its full-year EPS guidance to $3.00–$3.15 after reporting $16.7 billion in Q3 revenue.
30 November 2025
····
GE Vernova (GEV) Stock Near $600: Institutional Buying, Taiwan Wind Deal and AI Power Boom – November 30, 2025 Update

GE Vernova (GEV) Stock Near $600: Institutional Buying, Taiwan Wind Deal and AI Power Boom – November 30, 2025 Update

GE Vernova closed at $599.77 on Friday, up 1.7%, with after-hours trading near $598.10. Estabrook Capital Management increased its stake by 20.1% in the second quarter, now holding 10,799 shares valued at about $5.7 million. The stock is up nearly 74% year-to-date, driven by institutional buying and major energy projects. Market cap stands at roughly $162 billion.
30 November 2025
···
AbbVie Inc (ABBV) Stock on November 30, 2025: Analyst Downgrade, FDA Wins and Dividend Strength

AbbVie Inc (ABBV) Stock on November 30, 2025: Analyst Downgrade, FDA Wins and Dividend Strength

AbbVie shares closed November at about $227, up 32% year to date but down 3% for the week amid Medicare pricing pressures. The stock’s trailing P/E remains above 170 due to one-off charges, while forward P/E is in the mid-teens. Wall Street Zen downgraded AbbVie from “Strong Buy” to “Buy” on November 30. The average analyst price target sits in the mid-$240s.
30 November 2025
·
Citigroup (NYSE:C) Stock on 30 November 2025: ‘Moderate Buy’ Consensus, Big-Money Inflows and New Cyber-Risk Headlines

Citigroup (NYSE:C) Stock on 30 November 2025: ‘Moderate Buy’ Consensus, Big-Money Inflows and New Cyber-Risk Headlines

Citigroup closed at $103.84 on 28 November 2025, near its 52-week high of $105.59, with a market cap of about $186 billion. The stock has gained over 45% year-to-date and trades at a P/E ratio of 14.6. Analyst consensus rates it a “Moderate Buy” with an average 12-month price target of $108.70. American Century Companies increased its stake by 8.8% in Q2.
30 November 2025
·
Charles Schwab Stock on November 30, 2025: Latest News, Price Action, and Outlook for SCHW Investors

Charles Schwab Stock on November 30, 2025: Latest News, Price Action, and Outlook for SCHW Investors

Charles Schwab shares closed at $92.73 on Friday, up 1% and near 2025 highs, with the stock up 24% year-to-date. The company holds a market cap above $160 billion and a P/E in the low 20s. On November 30, Schwab’s asset-management arm reported portfolio adjustments in several U.S. equities, including a reduced stake in Rocket Lab and new shares in IonQ. No major corporate press releases were issued.
30 November 2025
·
Shopify Stock on November 30, 2025: Record Black Friday Sales, AI Surge and New Regulatory Risks

Shopify Stock on November 30, 2025: Record Black Friday Sales, AI Surge and New Regulatory Risks

Shopify merchants generated $6.2 billion in global Black Friday sales, up 25% year over year, with U.S.-listed shares closing at $158.64 on November 28, down 0.44%. The company reported strong Q3 growth but noted margin pressure and faces new U.S. regulatory scrutiny. Shopify stock is up about 49% year-to-date, with a market cap near $206.5 billion.
30 November 2025
···
Merck (MRK) Stock on November 30, 2025: Price, Fresh Analyst Calls, Cidara Deal and Dividend Outlook

Merck (MRK) Stock on November 30, 2025: Price, Fresh Analyst Calls, Cidara Deal and Dividend Outlook

Merck shares closed at $104.83 on November 28, 2025, near their 52-week high after a 22% surge in the past month. The stock spent much of early autumn in the mid-$80s before jumping above $100 following third-quarter earnings and positive November news. Analysts are split on valuation, with some models showing MRK as fairly priced and others suggesting significant upside.
30 November 2025
··
Booking Holdings (BKNG) Stock on November 30, 2025: Analyst Upgrades, AI Deals and Big-Money Buying Shape the Outlook

Booking Holdings (BKNG) Stock on November 30, 2025: Analyst Upgrades, AI Deals and Big-Money Buying Shape the Outlook

Booking Holdings reported Q3 revenue of $9.01 billion, up 13% year over year, and raised its annual cost-savings target to $500–550 million. Shares closed at $4,914.69 on Nov. 28, down 8.6% over the past year, underperforming the S&P 500. Institutional ownership stands at 96%. The company expects Q4 revenue growth of 10–12% and adjusted EBITDA of $2.0–2.1 billion.
30 November 2025
··
Omnicom Group (OMC) Stock on November 30, 2025: Interpublic Mega‑Merger, Dividend Hike and Debt Exchange Put Ad Giant at a Turning Point

Omnicom Group (OMC) Stock on November 30, 2025: Interpublic Mega‑Merger, Dividend Hike and Debt Exchange Put Ad Giant at a Turning Point

Omnicom closed its $13.25 billion all-stock merger with Interpublic on November 26, following European Commission approval. The combined company, trading as OMC, saw share volume surge to 9.2 million Friday, while the stock closed at $71.62, still 31% below its 52-week high. John Wren remains CEO; former IPG chief Philippe Krakowsky joins as Co-President.
30 November 2025
····
Lennar Stock (LEN): Exchange Offer Wraps, CEO Transition Looms as Wall Street Braces for Q4 2025 Earnings

Lennar Stock (LEN): Exchange Offer Wraps, CEO Transition Looms as Wall Street Braces for Q4 2025 Earnings

Lennar shares closed at $131.30 on November 28, down more than 20% from a recent 52-week high. The company completed an oversubscribed exchange offer, distributing 33.3 million Millrose Properties shares in return for 8 million Lennar shares. Major investors including Berkshire Hathaway have increased stakes, while Wall Street maintains a “Hold” rating. Lennar faces lower profit expectations and the retirement of Co-CEO Jon Jaffe.
30 November 2025
····
1 … 1,419 1,420 1,421 1,422 1,423 … 1,871

Stock Market Today

  • Cerebras Systems Nears IPO, Signaling New Competition for Nvidia (NVDA)
    April 27, 2026, 3:45 AM EDT. Cerebras Systems, backed by venture capital, is preparing for a U.S. initial public offering, challenging NVIDIA Corporation (NASDAQ:NVDA) in the artificial intelligence (AI) chip market. Cerebras claims to offer the fastest AI inference and training platform, using chips that differ from Nvidia's reliance on high-bandwidth memory. Notably, OpenAI, Amazon, and Meta are among Cerebras' customers, with a $20 billion contract involving OpenAI deploying 750 megawatts of Cerebras chips. While specifics of the IPO remain undecided, the move intensifies competition amid rapid AI chip market growth. Nvidia remains favored on Wall Street, with 93% of analysts rating it a Buy and an average 12-month price target suggesting over 32% potential upside.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 27.04.2026

27 April 2026
LIVEMarkets rolling coverageStarted: April 27, 2026, 12:00 AM EDTUpdated: April 27, 2026, 3:56 AM EDT Cerebras Systems Nears IPO, Signaling New Competition for Nvidia (NVDA) April 27, 2026, 3:45 AM EDT. Cerebras Systems, backed by venture capital, is preparing for a U.S. initial public offering, challenging NVIDIA Corporation (NASDAQ:NVDA) in the artificial intelligence (AI) chip market. Cerebras claims to offer the fastest AI inference and training platform, using chips that differ from Nvidia's reliance on high-bandwidth memory. Notably, OpenAI, Amazon, and Meta are among Cerebras' customers, with a $20 billion contract involving OpenAI deploying 750 megawatts of Cerebras chips. While
Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
Go toTop